CSIR’s Anti-Cancer Drug IIIM-290 enters Clinical Trial

CSIR constituent lab CSIR-Indian Institute of Integrative Medicine (IIIM) Jammu, has received Investigational New Drug (IND) approval from New Drugs Division …